Kwality Pharmaceuticals Limited (BOM:539997)
India · Delayed Price · Currency is INR 3,396.75
+80.05 (2.41%)
At close: Oct 16, 2026
Kwality Pharmaceuticals Market Cap
Kwality Pharmaceuticals has a market cap or net worth of 35.25 billion as of October 16, 2026. It is the 16,943rd most valuable company in the world and the 1,008th biggest in India. Its market cap has increased by 295.29% in one year.
Market Cap
35.25B
Enterprise Value
36.50B
Revenue
5.54B
Global Rank
Country Rank
#1,008 India
PE Ratio
43.49
ChartMarket Cap Chart
Since July 18, 2016, Kwality Pharmaceuticals's market cap has increased from 230.87M to 35.25B, an increase of 15,166.29%. That is a compound annual growth rate of 63.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 35.25B | 206.47% |
| Dec 31, 2025 | 11.50B | 27.87% |
| Dec 31, 2024 | 8.99B | 116.81% |
| Dec 29, 2023 | 4.15B | 5.27% |
| Dec 30, 2022 | 3.94B | -58.55% |
| Dec 31, 2021 | 9.51B | 1,561.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Morepen Laboratories | 70.06B |
| Sanofi India | 68.71B |
| FDC Limited | 56.85B |
| Evonile Pharma | 49.11B |
| Gufic Biosciences | 41.74B |
| Unichem Laboratories | 36.60B |
| Shukra Pharmaceuticals | 29.45B |
| Hikal | 26.95B |